<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....

Y*ffi,.{ffi,m* Date: 22'd June, 2026 The Deputy Manager (Department of Corporate Serrices), BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai-400001. Sub.: Initial Disclosure as per SEBI Circular(s) related to ..Large Corporate Framework " Ref.: Scrip Id: NOVELIX Code: 536565 Respected Sir/Madam, In response of email dated 19 Jtn 2026 from BSE Limited and in continuance of our earlier submission daled April 28, 2025 vide acknowledgement no. 9602495, we hereby confirm that, our company "Novelix Pharmaceuticats Limited" does not fall under the Large corporate (LC) category as per framework provided in the SEBI Circular SEBI/HO,DDHS/DDHS- RACPODIiP/CIN20231172 dated October 19,2023 and the provisions of the said circular are not applicable to orr company for the Financial year 2025-2026. Please find the attached "Annexure-A" - Format of the Initial Disclosure to be made by an entity identihed as a Large Corporate. Please take the same on your records. Thanking you, Yours Faithfully, For Novelix Pharmaceuticals Limited Nishita Kalantri (Company Secretary & Compliance OIIicer) Membership No.t A44773 Novelix Pharmaceuticals limited (Formerly Known as TRtMURTHI LlltlTE0) H No: l-6-2j7l61o, Flat No: 610, 6rh Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 5oooz9 Ph No: +91 89776j1o44 Email: rovetixphama(euticats@gmait.Gom www.trimurthidrugs.com #nffi.*ffi,m* Annexure I Initial disclosure of the company as per the format specified under SEBI circular SEBVHO/DDHS/DDHS-RACPODI lP I CIN2023 I t7 2 dated October t9 - 2O23 : Sr. No. Particulars Details Name of the Company Novelix Pharmaceuticals Limited 7 CIN L67 I20TGI994PLC0 I 8956 ^t. Outstanding borrowing of Company 0.00 Crores as on April 01,2024 (Rs. in Crores) 1. Outstanding borrowing of Company 0.00 as on March 31,2025 (Rs. in Crores) Highest Credit Rating during the NA previous FY along with name of the Credit Rating Agency issuing the Credit Rating assigning the Highest rating 6. Name of Stock Exchange in which the Not Applicable fine shall be paid, in case of shortfall in the required bonowing under the framework we confirm that we are not a Large corporate as per the applicability criteria given in the SEBI Circular SEBVHOiDDHS/DDHS-RACPODI lP I CLPJ2023 I 172 dated, October 19. 2021. Thanking You, Yours Faithfully, For Novelix Pharmaceuticals Limited .\'*$t rilhUr'^l v'/. Nishita Kalantri Bhoomika Choudhary (Company Secretary & Compliance Oflicer) (Chief Financial Officer) Membership No,: A44773 Novelix Pharmaceuticals limited (Formerly Known as TRI URTHI LI ITED) H No: l-6-217/61o, Flat No: 61o, 6rh Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 5ooo29 Ph No: +91 89776)1c,44 EmaiL novelixpharmaceuticals@gm.il.com www.trimurthidrugs.com